Clinical Trial Update: Effects of SGLT2 Inhibitor in Diabetic Patients With Coronary Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update on the effects of an SGLT2 inhibitor in diabetic patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Disease in Diabetes Mellitus

Snippet

Sponsor: Sheba Medical Center | Conditions: Coronary Disease With Diabetes Mellitus | Phase 4 | Status: UNKNOWN